Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business9 December 2014Corporate and M&ADeal watchUS firms One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRopes and Kirkland lead on EQT’s $3.7bn acquisition of secondaries leader CollerRevolving Doors: Sidley and Hogan Lovells swipe Latham partners, as Ropes and Clifford Chance build in EuropeBaker McKenzie, HSF Kramer and Dentons among big winners in new Legal 500 APAC rankingsBeyond the deals: how clients rate London’s top M&A teamsFreshfields and Slaughters among international line-up on €5bn Deutsche Börse dealRopes and Kirkland lead on EQT’s $3.7bn acquisition of secondaries leader Coller‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLegal 500 US: Latham tops the charts in new US rankingsDealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega deal